Markets.com Logo

MEIP

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    4.5944$
  • Previous Close
    4.6421$
  • 52 Week Change
    6.79$
  • Day Range
    -0.05$
  • 52 Week High/Low
    1.46$ - 8.25$
  • Dividend Per Share
    --
  • Market cap
    150 M$
  • EPS
    -0.3862
  • Beta
    0.215
  • Volume
    --

About

MEIP.US represents shares of MEI Pharma, Inc., a pharmaceutical company focused on the development and commercialization of novel cancer therapies. The company's pipeline includes clinical-stage drug candidates targeting various hematologic malignancies and solid tumors. Investors should conduct thorough research and consider their own risk tolerance before investing in MEIP.US.

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Global Markets Show Resilience Amidst Iran Conflict, But Underlying Risks Persist

Emma Rose|--

Iran War Threatens US Labor Market's 'Wonderful Balance': A Deep Dive

Emma Rose|--

Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment

Sophia Claire|--

US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks

Sophia Claire|--

Global Debt Crisis Deepens Amidst Iran Conflict and Fiscal Fragility

Ava Grace|--

Apple's Strategic Pivot: MacBook Neo, Supply Chain Tactics, and Foldable Phone Hurdles

Emma Rose|--

Factors

Mankind Pharma's (MEIP.US) stock price is influenced by various factors: Company Performance: Revenue, profit margins, and sales growth in key therapeutic areas (cardiovascular, anti-infectives, gastrointestinal, etc.) directly impact investor confidence. Positive earnings reports typically lead to stock appreciation. Pharmaceutical Market Trends: The overall growth rate of the Indian pharmaceutical market, increasing healthcare spending, and government policies affecting drug pricing all play a role. Regulatory Environment: Changes in drug regulations, pricing controls, and approval processes can affect MEIP's ability to launch new products and maintain profitability. Competition: The competitive landscape within the Indian pharmaceutical industry, including the presence of both domestic and international players, affects MEIP's market share and pricing power. Research and Development: Successful development and launch of new drugs and formulations can drive future growth and positively impact the stock price. Global Economic Factors: Broader economic conditions, such as inflation, interest rates, and exchange rate fluctuations, can affect investor sentiment and capital flows into the Indian stock market. Investor Sentiment: Overall market sentiment towards pharmaceutical stocks, influenced by news events, analyst ratings, and macroeconomic outlook, also affects MEIP's stock performance.

People Also Watch

Latest news

Close Coordination Between Israel and US on Iran Nuclear Talks Highlighted

Noah Lee|--

US-Iran Talks Show Progress Towards Ceasefire Framework Agreement

Liam James|--

Federal Reserve Independence Under Historic Test: Navigating Democratic Legitimacy and Political Pressure

Liam James|--

Latest Education Articles

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Frances Wang|--
Bull vs. Bear Markets: What's the Difference?

Bull vs. Bear Markets: What's the Difference?

Julian Parker|--
Recommended Topics